Wyeth Wins Round 2 In Trio Of Fen-Phen Suits

Law360, New York (July 28, 2010, 3:03 PM EDT) -- For the second time this week a state appeals court has affirmed the dismissal of a suit over Wyeth Inc.'s fen-phen, this time finding that the plaintiff could not prove causation because she did not actually suffer from one of the drug's nondisclosed risks.

In a ruling Tuesday, the Superior Court of Pennsylvania held that Pennsylvania law does not allow a plaintiff to prove proximate causation where a drug manufacturer’s warning disclosed a risk of injury and the plaintiff sustained that very injury, but the manufacturer...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.